A detailed history of Rothschild Investment Corp transactions in Viatris Inc stock. As of the latest transaction made, Rothschild Investment Corp holds 31,190 shares of VTRS stock, worth $411,084. This represents 0.03% of its overall portfolio holdings.

Number of Shares
31,190
Previous 26,235 18.89%
Holding current value
$411,084
Previous $262,000 17.56%
% of portfolio
0.03%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 16, 2023

BUY
$9.59 - $11.35 $47,518 - $56,239
4,955 Added 18.89%
31,190 $308,000
Q2 2023

Jul 18, 2023

SELL
$9.02 - $10.29 $26,185 - $29,871
-2,903 Reduced 9.96%
26,235 $262,000
Q1 2023

Apr 24, 2023

SELL
$9.2 - $12.26 $27,489 - $36,632
-2,988 Reduced 9.3%
29,138 $280,000
Q4 2022

Jan 19, 2023

SELL
$8.72 - $11.56 $16,820 - $22,299
-1,929 Reduced 5.66%
32,126 $358,000
Q3 2022

Oct 21, 2022

SELL
$8.48 - $11.13 $259,488 - $340,578
-30,600 Reduced 47.33%
34,055 $290,000
Q2 2022

Jul 12, 2022

SELL
$9.95 - $12.27 $20,855 - $25,717
-2,096 Reduced 3.14%
64,655 $677,000
Q1 2022

Apr 18, 2022

SELL
$9.81 - $15.4 $42,163 - $66,189
-4,298 Reduced 6.05%
66,751 $726,000
Q4 2021

Jan 24, 2022

BUY
$12.09 - $14.68 $53,461 - $64,914
4,422 Added 6.64%
71,049 $961,000
Q3 2021

Oct 12, 2021

SELL
$13.25 - $15.13 $5,498 - $6,278
-415 Reduced 0.62%
66,627 $903,000
Q2 2021

Jul 19, 2021

BUY
$12.97 - $16.15 $531,277 - $661,536
40,962 Added 157.06%
67,042 $958,000
Q1 2021

Apr 15, 2021

SELL
$13.59 - $18.54 $60,380 - $82,373
-4,443 Reduced 14.56%
26,080 $364,000
Q4 2020

Jan 25, 2021

BUY
$14.3 - $18.74 $436,478 - $572,001
30,523 New
30,523 $572,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $16B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Rothschild Investment Corp Portfolio

Follow Rothschild Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment Corp , based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment Corp with notifications on news.